195 related articles for article (PubMed ID: 34340980)
1. Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer.
Meroni PL; Borghi MO
Ann Rheum Dis; 2021 Sep; 80(9):1105-1107. PubMed ID: 34340980
[No Abstract] [Full Text] [Related]
2. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD
Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454
[No Abstract] [Full Text] [Related]
3. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.
Trahtemberg U; Rottapel R; Dos Santos CC; Slutsky AS; Baker A; Fritzler MJ
Ann Rheum Dis; 2021 Sep; 80(9):1236-1240. PubMed ID: 33903092
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid Antibodies and Infection:
Sciascia S; Radin M; Bazzan M; Montaruli B; Cosseddu D; Norbiato C; Bertero MT; Carignola R; Bacco B; Gallo Cassarino S; Roccatello D
Front Immunol; 2021; 12():687534. PubMed ID: 34220842
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome.
Asherson RA; Shoenfeld Y
J Rheumatol; 2003 Feb; 30(2):214-9. PubMed ID: 12563670
[No Abstract] [Full Text] [Related]
6. Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.
Li Q; Li J; Zhou M; Ge Y; Liu Z; Li T; Zhang L
Front Immunol; 2024; 15():1354349. PubMed ID: 38707895
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Pavoni V; Gianesello L; Horton A
J Thromb Thrombolysis; 2021 Aug; 52(2):542-552. PubMed ID: 33973157
[TBL] [Abstract][Full Text] [Related]
8. Recent Developments in Antiphospholipid Antibodies and the Antiphospholipid Syndrome.
Urbanus RT
Semin Thromb Hemost; 2018 Jul; 44(5):417-418. PubMed ID: 29940673
[No Abstract] [Full Text] [Related]
9. Antiphospholipid antibodies and the antiphospholipid syndrome.
Asherson RA; Cervera R; Gharavi AE
Ann Med Interne (Paris); 1993; 144(5):367-76. PubMed ID: 8291853
[No Abstract] [Full Text] [Related]
10. Antiphospholipid antibodies and COVID-19.
La Cava A
Autoimmun Rev; 2021 Oct; 20(10):102910. PubMed ID: 34303846
[No Abstract] [Full Text] [Related]
11. High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Pineton de Chambrun M; Frere C; Miyara M; Amoura Z; Martin-Toutain I; Mathian A; Hekimian G; Combes A
J Intern Med; 2021 Mar; 289(3):422-424. PubMed ID: 32529774
[No Abstract] [Full Text] [Related]
12. Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection.
Bitterman L; Solhjoo M; Shah V; Kwon SM; Torralba K; Kazbour H
J Investig Med High Impact Case Rep; 2023; 11():23247096231165736. PubMed ID: 37052044
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in our understanding of the antiphospholipid syndrome.
De Groot PG; Meijers JC; Urbanus RT
Int J Lab Hematol; 2012 Jun; 34(3):223-31. PubMed ID: 22394675
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study.
Erden A; Karakas O; Armagan B; Guven SC; Ozdemir B; Atalar E; Apaydin H; Usul E; Ates I; Omma A; Kucuksahin O
Bratisl Lek Listy; 2022; 123(2):120-124. PubMed ID: 35065587
[TBL] [Abstract][Full Text] [Related]
15. Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome.
Klemm P; Müller-Ladner U; Tarner IH; Lange U; Hudowenz O
Autoimmun Rev; 2020 Aug; 19(8):102594. PubMed ID: 32535091
[No Abstract] [Full Text] [Related]
16. Antiphospholipid antibodies: neuropsychiatric presentations.
Gris JC; Brenner B
Semin Thromb Hemost; 2013 Nov; 39(8):935-42. PubMed ID: 24129681
[TBL] [Abstract][Full Text] [Related]
17. A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome.
Viner M; Murakhovskaya I
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):411-415. PubMed ID: 27898514
[TBL] [Abstract][Full Text] [Related]
18. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Cervera R; Rodríguez-Pintó I; Legault K; Erkan D
Lupus; 2020 Oct; 29(12):1594-1600. PubMed ID: 32819183
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies: immunological aspects.
Roubey RA
Clin Immunol; 2004 Aug; 112(2):127-8. PubMed ID: 15240154
[No Abstract] [Full Text] [Related]
20. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
Pérez D; Tincani A; Serrano M; Shoenfeld Y; Serrano A
Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
